To further investigate mechanisms of cell-mediated tissue destruction in an organ-specific autoimmune disease, we have established and characterized a nephritogenic CD8+ T cell line. This target antigen-specific effector T cell line, M52, was derived from bulk populations of CD8+ T cells isolated from susceptible animals immunized to produce anti-tubular basement membrane (alpha TBM) disease. Our studies show that M52 retains the phenotypic and functional characteristics of nephritogenic T cells induced in vivo. M52 mediates antigen-specific delayed-type hypersensitivity (DTH) responses to the target antigen 3M-1, it is cytotoxic to 3M-1-expressing renal tubular epithelial cells in vitro, and it adoptively transfers interstitial nephritis to naive syngeneic recipients. Clonal analysis of these nephritogenic CD8+ T cells reveals distinct functional phenotypes within the M52 cell line. We have isolated a cytotoxic CD8+ clone, M52.26, which is not DTH-reactive to 3M-1, and multiple DTH-reactive clones which mediate less efficient cytotoxicity to 3M-1-expressing target cells. Cytofluorographic analysis of four randomly selected clones reveals alpha beta T cell receptor expression. Further characterization of these functionally distinct CD8+ T cell clones will help to define their respective roles in mediating tubular epithelial cell injury and the inflammatory lesion of autoimmune interstitial nephritis.
Introduction
Major advances in cellular and molecular immunology over the past decade have resulted in increasingly sophisticated analyses of the T cell repertoire in experimental autoimmune diseases (1) (2) (3) . We have been interested in using models of autoimmune interstitial nephritis to understand immune system recognition of native renal antigens and the mechanisms by which activated lymphocytes elicit renal injury. One model studied extensively is anti-tubular basement membrane Receivedfor publication 28 February 1991.
(aTBM) disease in inbred mice (4) (5) (6) (7) . This form of progressive renal injury is produced by immunizing susceptible strains of mice (H-2KId) with collagenase-solubilized renal tubular antigens (SRTA)' in CFA. By 2 wk after immunization, aTBM Abs are detectable in the kidney and after 6-8 wk mononuclear cells appear within the renal interstitium (4) . The interstitial infiltrate becomes more intense with time and eventually results in tubular atrophy and interstitial fibrosis, with the functional consequence of progressive renal insufficiency.
The target antigen ofboth human and experimental aTBM disease has been purified (8, 9) . This glycoprotein antigen, called 3M-1, displays conserved antigenicity across mammalian species. In the kidney 3M-1 is synthesized by proximal tubular epithelial cells (8) and is largely secreted into the extracellular matrix in close proximity to the tubular basement membrane. 3M-1 is also expressed on the proximal tubular cell membrane, albeit in lesser amounts than present in the extracellular matrix (10) . As the cDNA sequencing ofthis glycoprotein has revealed five distinct sequences at the 5' end, the membrane-associated and matrix proteins may well be separate 5' isoforms of the 3M- 1 
antigen (1 1).
Previous studies have demonstrated that there are two distinct 3M-1 reactive T cell subsets found within the interstitial infiltrate of aTBM disease (12) . Both subsets elicit an inflammatory interstitial lesion following adoptive transfer, but under quite different conditions (6, 13) . A CD4+, class II-restricted (I-Al) T cell subset adoptively transfers interstitial nephritis 6-10 wk after intravenous injection into naive syngeneic hosts (13) . The CD8+ class I-restricted (H-2K') subset from immune mice acutely induces disease within 3-5 d, if transferred directly under the renal capsule (6) . Subcapsular transfer of the CD4+ immune T cells does not induce interstitial disease (6) . Previous studies have also demonstrated that the delayed-type hypersensitivity (DTH) response to 3M-1 is a valid assay of CD8+ effector T cell function, and is not mediated by CD4+ T cells in susceptible mice (6) . Tubular antigen-specific DTH responses are demonstrable after antigen challenge following either subcutaneous immunization with renal tubular antigen (RTA) in CFA or intravenous transfer ofimmune T cells (6) . In addition, CD8+ T cells that mediate DTH can be isolated from the interstitium ofdiseased animals. From this, and other studies (13) (14) (15) , we have concluded that the CD8+ T cells are the ultimate effector T cells of this disease.
To evaluate more precisely the mechanisms of interstitial damage by CD8' effector cells, we have developed a number of immunologic reagents to facilitate our analysis of T cell-epithelial cell interactions. MCT is a murine proximal tubular epithelial cell line established from microdissected tubules of naive SJL mice (10) . This cell line expresses abundant cell-surface class I MHC as well as small amounts of class II, both of which can be augmented with IFN-'y (16) . MCT cells secrete an extracellular matrix consisting primarily of laminin, types IV and V collagen, with lesser amounts of types I and III collagen. MCT cells also synthesize and secrete the target 3M-I antigen of aTBM disease (10) . Since MCT cells can synthesize both 3M-I and class I MHC antigens, we anticipated that they may coexpress 3M-1 peptide fragments with class I MHC determinants as a complex which would be recognized by 3M-i -reactive CD8' T cells. This report details our initial characterization ofM52, a CD8' effector T cell line which transfers interstitial nephritis, and its interaction with tubular epithelium.
Methods
Mice. SJL mice (H-2') were purchased from the Jackson Laboratory, Bar Harbor, ME.
Antigens. Rabbit renal tubular basement membranes were isolated by a differential sieving technique, sonicated, lyophilized, and stored at -20'C (4). Lyophilized RTA was emulsified in CFA at antigen concentration of 4 mg/ml for both RTA and purified protein derivative (PPD). SRTA was made from these lyophilized membranes by collagenase digestion (17) . The 3M-I glycoprotein is isolated from SRTA using immunoaffinity chromatography with a monoclonal aTBM-Ab (8) . The resultant filtrate, SRTA depleted of 3M-I was also used to assess antigen specificity in certain experiments. P1 and P2, two synthetic peptides derived from the cDNA sequences of 3M-1, were manually synthesized by the simultaneous multiple peptide method of Houghten (18) . Amino acid sequences ofthese peptides are as follows: P1, LLRRRHGDRRSTMSAEVP; P2, ASAEEQKEMEDKVTSPE-KAEEA ( 1i). PPD was obtained from Connaught Laboratories, Ltd., Willowdale, Ontario, Canada.
Isolation of T cell lines (M52 and M61). Draining lymph nodes were harvested from SJL mice 14 d after immunization with either 2 mg of RTA/CFA or CFA alone. Lymph nodes were finely minced into small pieces, and gently pressed through a mesh sieving screen. Cells were washed with PBS and then incubated with monoclonal aB cell Ab (19) , monoclonal aCD4 Ab (from GK 1.5 hybridoma [20, 21J) , and a mixture of rabbit and guinea pig C (4). Remaining viable CD8+ cells were plated at a density of 0.5 X 106/well of a 24-well tissue culture plate. The cell line and clones were propagated by weekly passage with 20 jg/ml antigen (SRTA, P1, or PPD), 20% MLA-144 supernatants as a source of IL-2 and other growth factors (22) , and 5 X I0 irradiated (2,500 rads) syngeneic spleen cells. The M52 cell line was cloned by limiting dilution. T cells were plated at a density of 0.3 cells/well in a 96-well microtiter plate with irradiated syngeneic splenocytes, IL-2, and antigen (SRTA or P1). Wells with evidence of T cell growth were then transferred to 24-well plates and further expanded by weekly stimulation. The surface phenotype of the clones was verified by antibodymediated cytotoxicity using either GK 1.5 or aCD8 (from hybridoma 3.168.8 [23] ) with C. T (14) . They were used for cytotoxicity assays at confluence. The renal fibroblasts (TFB), also harvested from SJL mice, were grown under the same culture conditions as the MCT cells and also used at confluence. Local adoptive transfer ofDTH. The adoptive transfer of DTH has been described in detail (6) . In brief, cultured T cells were washed and resuspended at 2.0 X I0 cells/ml in SRTA (1 mg/ml), PPD (1 mg/ml), 3M-I (1 mg/ml), PI (1 mg/ml), P2 (1 mg/ml), or PBS, and 25 ,d ofeach cell preparation was injected into the hind footpads of recipient mice (three to four mice per group). Footpad swelling as an index of DTH was measured 24 h later using a spring-loaded engineer's micrometer (model 7308; Mitutoyo/MTI Corp., Paramus, NJ). The magnitude of swelling was expressed as the mean increment between the footpad injected with cells in antigen and that injected with cells in PBS in inches x I0-3+SEM. In some experiments, T cell subpopulations were selectively depleted by incubation with aCD8 or aCD4 MAb and a mixture ofrabbit and guinea pig C before adoptive transfer. All footpad measurements were performed by an individual blinded to the experimental protocol.
Adoptive transfer ofdisease. These subcapsular transfers have been previously described (6 7 d later the kidneys were harvested and longitudinally sectioned with preservation of the subcapsular cell layer. After fixation in 10% buffered formalin, the kidneys were paraffin embedded for staining with hematoxylin and eosin. The kidneys were then examined histologically for the presence of interstitial injury.
Assessment of renal disease. The stained kidney sections were coded for blind reading by two different grading scales. The severity was qualitatively assessed with a scale used in previous studies (6): 0 = no involvement from the subcapsular cell layer, 0.5 = trace pathologic changes of cellular involvement in a focal pattern in the outermost cortical tubular area; I = superficial, focal peritubular infiltration and tubular atrophy under the transferred cell layer; 2 = focal, deeply extending, heavy cellular infiltrates with peritubular damage and tubular atrophy. The sections were also graded by approximating the tubular layer cell depth of the most advanced infiltrating front of mononuclear cells. Each layer equalled a tubular diameter and was given one point. The data from both methods were expressed as a mean for each group±SEM.
Cytotoxicity assays. This method determines target cell viability (24, 25) . Target cells, either MCT or TFB cells, were prepared from confluent cultures by light trypsinization (Sigma Chemical Co., St. Louis, MO) and washed once in appropriate serum-containing medium. Cells were then resuspended at 1.0 X 106/ml in complete medium containing 0.5 ,g/ml mitomycin C (Sigma), vigorously vortexed, and 20-IA aliquots were dispensed into 96-well flat-bottomed microtiter plates. 180 gl of mitomycin C-containing medium (0.5 gg/ml) was then added to each well. Target cells were allowed to attach by overnight incubation at 370C, 5% CO2. Effector T cells were harvested from day 5 cultures containing irradiated syngeneic feeders, IL-2, and antigen, and separated by Lympholyte (Cedarlane Laboratories, Ltd., Hornby, Ontario, Canada) extraction at room temperature. The interface cell layer containing viable T cells was washed with fresh medium and resuspended at 10 X 106 cells/ml. Appropriate aliquots were then added to the adherent target cells at effector/target (E/T) ratios of 5/1-100/1 in triplicate. Plates were incubated for 16-20 h at 370C and 5% CO2. Four wells containing target cells received no effector cells as a control for MCT cell viability and four wells containing only medium were used to control for nonspecific dye reduction. After effector cell incubation, T cells were washed from the microtiter wells with warmed (370C) medium, and the wells were replated with 180 ul of fresh medium. 20 Ml of 3(4,5-dimethylthiazol-2-yl)2,5 diphenyltetrazolium bromide (MTT) dye (Sigma) solution (5 mg/ml in PBS) was added to each well and the plate was incubated for 4 h at 370C, 5% CO2. After this incubation, medium and unreacted dye were aspirated from the wells and 180 Ml of 0.04 N HCI in isopropanol was added to solubilize the formazan dye. In addition, 20 Ml of 3% SDS solution was added to each well to solubilize alcohol-induced protein precipitates. The OD at 570 nm ofeach well was then determined using a spectrophotometer (Beckman Instruments, Inc., Fullerton, CA). The mean and standard deviation were determined for triplicate samples. The percent cytotoxicity was calculated by the following equation: % cytotoxicity = (1 -OD treated/OD control) X 100.
Blocking antibody studies. These studies were conducted at an E/T ratio of 25/1. Cytotoxicity assay plates were set up as described above. Varying concentrations of monoclonal antibodies aCD8 (23), aCD4 (20, 21) , aH-2K' (26), aH-2Kk (27) , or aThy 1.2 (19) were added to either effector T cells or target cells (H-2K!) before the experiment. After overnight incubation, plates were washed, and MTT was added to each well. The OD readings were conducted at 570 nm to determine cell viability. Results were then compared to control wells to which no antibody was added.
Southern hybridization studies. Liver and M52 clonal DNA were isolated with standard methods (28). Each sample, containing 10 g of genomic DNA, was digested to completion with a restriction enzyme (Hind III, Boehringer Mannheim Corp., Indianapolis, IN), separated on a 0.7% agarose gel, and transferred to a Zetabind" membrane (Cuno Laboratory Products, Meriden, CT). The blots were prehybridized and hybridized at 550C in 0.5 M NaPO4 buffer, 7% SDS, 1% BSA, 1 mM EDTA, 50 gg/ml Poly A (Boehringer Mannheim), and 50 Mg/ml ssDNA. The blots were hybridized to a 32P-labeled (random-primed) Statistical analysis. Differences between experimental groups were determined by Student's t test, where appropriate. Cytotoxicity curves were evaluated using two-way analysis of variance (32) .
Results
General characterization ofthe M52 cell line. Previous studies from our laboratory have demonstrated that adoptive transfer of bulk populations of CD8+, 3M-I-specific T cells results in a histologic lesion very similar to that seen after immunization with RTA in CFA (6, 14) . The major histologic difference between disease caused by active immunization and adoptive transfer of immune cells is the absence, after adoptive transfer of CD8+ T cells, of aTBM-Abs. These CD8' effector T cells also transfer DTH to the target antigen, a property that has facilitated their characterization (6) . The M52 cell line was isolated from CD8' T cells harvested from SJL mice immunized with RTA/CFA. Since long-term in vitro culture can alter T cell specificity and function, we performed a number ofstudies to assess whether cultured M52 cells retained the functional characteristics of immune CD8' cells from immunized mice. (8) . Although previous work has suggested that 3M-I is the dominant immunogenic protein in this preparation, we confirmed the antigenic specificity of M52 cells. Table II shows that M52 cells transfer a DTH response to SRTA or to the purified target antigen 3M-1, but not to SRTA depleted of 3M-I by immunoaffinity chromatography (8) . The cDNA encoding murine 3M-1 has been recently sequenced (11) . Two nonoverlapping peptides derived from this sequence were also used as antigens in the local adoptive transfer of DTH with M52 cells. Other studies from our laboratory have demonstrated that P1, but not P2, is recognized by both a 3M-I-specific CD4' T helper clone, as well as a monoclonal a3M-1 antibody (11). As seen in Table II , M52 cells recognize P1, but not P2. Although we have not ruled out the possibility that other regions of 3M-1 are immunogenic in SJL mice, the P1 fragment is emerging as an immunodominant epitope in this strain. M52 cells elicit an inflammatory interstitial lesion after adoptive transfer. The M52 cell line was started from lymphocytes isolated from mice 2 wk after immunization, or before the onset of disease. We examined the in vivo function of the cell line by examining its ability to induce interstitial nephritis in naive recipients. In previous studies we have found that renal subcapsular transfer of immune T cells is a sensitive and reproducible means ofdetermining the ability ofdiscrete T cell subsets to elicit inflammation in the renal interstitium (6, 13, 14) . To compare the nephritogenic potential of M52 cells with these previous studies, we used this same technique. 7 d after subcapsular injection, kidneys were harvested and evaluated by light microscopy for both severity of injury and maximum depth of infiltrating cells (described in Methods). Panels A and C of Fig. 1 (33, 34) . To further characterize the functional attributes of M52 cells we evaluated their cytotoxic potential against a renal proximal tubular epithelial cell line, MCT (10) . Since MCT cells synthesize the 3M-I glycoprotein, and express class I and small amounts of class II MHC glycoproteins on the cell surface, we reasoned they may be recognized by M52 cells. We employed a colorimetric assay designed for cytotoxic assays of adherent cells (as MCT is) (24, 25) to examine whether M52 was cytotoxic to MCT. As shown in Fig. 2 , M52 cells display dose-dependent cytotoxicity toward MCT cells between E/T ratios of 5/1 and 75/1, above which 100% cytotoxicity is typically observed. A number ofcontrol studies were performed to examine the specificity of this interaction. CD8' PPD-reactive M6 1 cells display minimal cytotoxicity to MCT, and M52 cells are not cytotoxic to cultured renal fibroblasts from SJL mice, which express class I MHC but not the target 3M-I antigen (1 1, 100- M52-mediated cytotoxicity is blocked by antibodies to CD8 or class I MHC. We examined whether cytolysis of MCT cells by M52 was a conventional cytotoxic T lymphocyte-target cell interaction in follow-up studies using blocking antibodies. These studies were carried out at an E/T ratio of 25/1, where a relatively small change in E/T ratio results in a significant change in cytotoxicity to MCT cells. As seen in Fig. 3, A and B, either aCD8 or aH-2K5 interfere with M52-mediated cytotoxicity, in a dose-dependent manner. aCD4, aH-2Kd, or aThy 1.2, as a control antibody recognizing another cell-surface determinant on M52 cells, did not significantly interfere with M52-mediated cytotoxicity of MCT cells.
The M52 cell line is comprised oftwofunctionally distinct CD8+ subsets. The functional studies described above raised the obvious question of whether DTH Fig. 4 , all four clones demonstrated cytotoxicity to MCT cells. These studies were repeated several times and consistently showed two distinct patterns of cytotoxicity. M52.26, the clone which (8.3, 8.7, 9 .0, and 12.6 kb, respectively) which differ from the germline configuration. Cell-surface expression of TcR on these clones was confirmed with cytofluorography. Fig. 6 demonstrates the expression of af3 TcR, and absence of 'y TcR, on these immunocompetent CD8' M52 effector clones. min presentation, however, support the notion that exogenous antigens can be presented with class I MHC (37) . CD4+ T cells, on the other hand, typically recognize exogenous antigen, processed by APC, in association with class II MHC (38) . We have previously shown that 3M-1-specific DTH-reactive CD4+ T cells also expand after immunization to produce aTBM disease (12) . Unlike the CD8+ effector cells, the CD4' effector cells do not typically infiltrate the kidney to cause inflammatory interstitial nephritis, a functional deficit that can be largely attributed to low basal levels of class II MHC expression in kidney tubular epithelium. When class II MHC expression is increased with IFN-y, CD4' effector cells do infiltrate the kidney (16) . In this setting of augmented renal class II expression, it is unknown whether epithelial cell 3M-I in vivo is presented to CD4+ effector cells by tubular cells or other more traditional APC. Studies performed in vitro, however, suggest that tubular epithelial cells can present self-synthesized antigen to class IIrestricted CD4+ T cell clones (35) . M52-mediated cytotoxicity of MCT cells can be inhibited by antibodies to CD8 or class I MHC, suggesting that the interaction of these autoimmune effector T cell clones with renal epithelium conforms to the conventional "rules" of cytotoxic T cell-target cell recognition (36) . These findings should not be interpreted, of course, to mean that the TcR/CD8 interaction with a complex of class I MHC and target peptide on the MCT cell surface is the only important cell-cell interaction. In view of recent studies on lymphocyte-endothelial interactions, it is quite likely that the M52-MCT interaction is also strengthened by interactions between adhesion molecules and integrins (39, 40) . It is also important to note that in vitro cytotoxicity studies largely overlook any role played by cytokines or antigen-specific immune reactants, which in vivo may serve to either augment or diminish the efficiency ofthe CD8' effector cell-MCT interaction. IFN-y and tumor necrosis factor-a, for example, have potent stimulatory effects on MHC antigen expression by a variety of cell types, including (in the case of IFN-,y) MCT cells (16, 41 We were fortunate to find a peptide region of the 3M-I molecule that is recognized by autoimmune effector T cells. Both P1 and P2 were selected from the open reading frame ofa cDNA clone initially isolated from a Xgtl 1 library through screening with polyclonal aTBM antisera (1 1). Studies thus far support the hypothesis that P1 is a highly immunodominant region of the 3M-1 glycoprotein, since it is recognized by both helper and effector T clones. Curiously, it is also recognized by a monoclonal aTBM Ab, and is therefore an example of an antigenic epitope that can be recognized by TcR and antibody ofthe same antigenic specificity (1 1). Our studies do not eliminate the possibility of other immunogenic epitopes within 3M-1 which are important for the full expression of the autoimmune response. A precedent certainly exists for other minor immunogenic determinants in autoimmune disease (1, 3). The major immunogenic epitopes of 3M-1 may also be different in mice of different MHC haplotypes, or those who express TcR variable (V) genes that have been deleted in the SJL mouse (55) . These issues are currently under investigation.
Autoimmune effector T cells have been characterized in several autoimmune disease models (42) (43) (44) (45) (2, 56, 57) , making it possible to use aTcR Ab recognizing specific V(3 families as a therapeutic modality (2, 57) . Autoimmune T cells in collagen-induced arthritis in mice may also demonstrate a bias in V (3 usage (58) . In several other autoimmune diseases, both CD4+ and CD8+ T cells are important in mediating organ damage. In murine experimental autoimmune thyroiditis, for example, adoptive transfer of thyroglobulin-specific CD4+ T cells results in thyroiditis, but CD8+ T cells are important in later stages of the disease (44) . Both CD4+ and CD8+ T cells are required for the adoptive transfer of diabetes in the NOD mouse model (59, 60 In murine aTBM disease, adoptive transfer ofeither CD41 or CD8' antigen-specific T cells will result in interstitial nephritis, albeit with different kinetics. CD4' T cells are not the ultimate effector cell but rather function to induce CD8' effector cells in the recipient (6, 13) . It is ofinterest that in a spontaneous model of autoimmune interstitial nephritis, the T cells responsible for adoptive transfer ofdisease are also CD8', suggesting that the initial T cell injury to the kidney is frequently class I-restricted (33) . As mononuclear cells infiltrate the kidney, and class II MHC expression is augmented by elaborated cytokines, CD4' effector cells may also be recruited and function to sustain autoimmune injury. The chronic phases of autoimmune injury may also be maintained by immune responses to neoantigens expressed by damaged parenchymal cells. We are currently using the reagents described here to define more precisely the mediators ofepithelial cell damage by autoimmune T cells, as well as those aspects of target cell biology altered by nonlytic interactions with T cells.
